ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0938

Short Term Antibiotic Treatment Improves the Neurobehavioral Phenotype of MRL/lpr Mice

Melodie Zaknoun1, Doaa Tehawey1, Baruh Polis1 and Chaim Putterman2, 1Azrieli Faculty of Medicine, Safed, Israel, 2Albert Einstein College of Medicine, Safed, Israel

Meeting: ACR Convergence 2025

Keywords: microbiome, Mouse Models, Lupus, neuropsychiatric disorders, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0934–0954) Systemic Lupus Erythematosus – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Neuropsychiatric lupus (NPSLE) is a common and prognostically significant manifestation of SLE, affecting 20-40% of lupus patients. The ACR identified 19 clinical syndromes associated with NPSLE, which range from severe manifestations such as psychosis and transverse myelitis to milder involvement in the form of headaches, mood disorders, and cognitive deficits.The gut microbiota has been implicated in the pathogenesis of autoimmune diseases, including SLE. Microbes significantly influence mammalian metabolism, the immune system, and behavior. The gut-brain axis is a communication network connecting the CNS with the gut’s enteric nervous system, facilitating information exchange between the brain and digestive functions. Recent studies emphasize the gut microbiota’s crucial role in this relationship.Our goal was to examine whether modulation of the gut-brain axis using a short course of antibiotic treatment would affect the development, progression, and severity of neuropsychiatric disease in the MRL/lpr strain.

Methods: Antibiotic Treatment: 6-week-old MRL/MpJ and MRL/lpr mice were given vancomycin 0.5 g/L in drinking water for 2 weeks, with the water being refreshed every 3 days. Control mice of these strains received regular water with no additives. Behavioral Testing: After 2 weeks of treatment, the mice were given 4 weeks for gut microbiome recovery. Behavioral testing began at 12 weeks of age, and included standard tests for depressive-like behavior (Porsolt swim test), thermal hypersensitivity (hot plate), anxiety (elevated plus maze (EPM)), and cognition/memory (novel object location (NOL)), with rest periods of 1-3 days between the tests.

Results: Porsolt swim test: MRL/lpr showed significantly worse depressive-like (despair) behavior as shown by increased immobility in the Porsolt swim test (75.1+/-2.2 seconds) as compared to the MRL/MpJ group (65.3+/-4.7; P < 0.0001). Moreover, antibiotic-treated MRL/lpr showed significant attenuation of this phenotype (less immobility), as compared to non-treated MRL/lpr mice (Figure 1A). Hot plate: Antibiotic treated MRL/lpr mice showed significantly increased latency until hind paw licking (114.5+/-10.7 vs 98+/-7.4 in the untreated group, p=0.029), indicating decreased thermal hypersensitivity and improved nociception. No significant change was observed in thermal hypersensitivity with antibiotic treatment in the MRL/MpJ strain (Figure 1B). EPM: Untreated MRL/MpJ mice displayed less anxiety as compared to MRL/lpr mice, as reflected by significantly more time spent in the open arms (15.5+/- 9.9 vs 1.9+/-1.2, p=0.018). Notably, antibiotic treated MRL/lpr mice trended to less anxiety compared to the untreated MRL/lpr group (Figure 2A). Novel Object Location: Although untreated MRL/lpr mice did appear to have the worst performance on this cognitive test of spatial memory, no significant differences were observed between the groups (Figure 2B).

Conclusion: A short term course of intestinal decontamination with oral vancomycin attenuates several key features of neuropsychiatric disease in MRL/lpr lupus mice. Studies to determine the effects on other disease features and elucidate the mechanisms of protection are in progress.

Supporting image 1Figure 1: A. In the Porsolt swim test, the mouse is placed in a water filled cylinder for 10 minutes. Mobility time was measured, and immobility is calculated based on the ratio of time that the mice were immobile (i.e. displaying despair, or depressive-like behavior) over the total time. B. To test thermal hypersensitivity, mice are placed on a plate heated to a temperature of 40°C and increasing to 52°C within three minutes. The latency, or response time, for the mice to lick their hind paws was measured for analysis.

Supporting image 2Figure 2: A. To assess for anxiety, the elevated plus maze test was employed. The maze was placed in a dark infra-red lit room and the mouse placed on the maze for 5 minutes. Time spent in open arms compared to the total time was recorded and analyzed using Ethovision software. B. In assessing memory with the novel object location test, each mouse was first placed in an arena with two similar objects for 5 minutes. After an interval of 60-90 minutes, the mouse is put in the same arena in which one of the objects was moved to a new location. The preference index (normal >50%) was calculated by dividing the time spent in the area of the newly moved object by the total time spent in both object zones.


Disclosures: M. Zaknoun: None; D. Tehawey: None; B. Polis: None; C. Putterman: Cullinan, 1, Progentec, 1.

To cite this abstract in AMA style:

Zaknoun M, Tehawey D, Polis B, Putterman C. Short Term Antibiotic Treatment Improves the Neurobehavioral Phenotype of MRL/lpr Mice [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/short-term-antibiotic-treatment-improves-the-neurobehavioral-phenotype-of-mrl-lpr-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/short-term-antibiotic-treatment-improves-the-neurobehavioral-phenotype-of-mrl-lpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology